DIC - Nursing Case Study

Pathophysiology

• Primary mechanism: DIC is initiated by the widespread activation of the coagulation cascade, often due to exposure of tissue factor, leading to excessive thrombin generation and formation of fibrin clots throughout the vasculature.

• Secondary mechanism: The consumption of clotting factors and platelets results in their depletion, causing a paradoxical risk of severe bleeding due to the inability to form stable clots when needed.

• Key complication: Microvascular thrombi and subsequent ischemia can lead to multi-organ dysfunction, while concurrent bleeding increases mortality risk, necessitating prompt recognition and management.

Patient Profile

Demographics:

57-year-old female, retired laboratory technician

History:

• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Chronic Kidney Disease Stage 3

• Current medications: Lisinopril, Metformin, Insulin, Atorvastatin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe abdominal pain and unexplained bleeding

• Key symptoms: Shortness of breath, confusion, extensive bruising, hematuria, and petechiae

• Vital signs: Blood pressure 85/50 mmHg, heart rate 130 bpm, respiratory rate 28 breaths per minute, temperature 101.3°F, oxygen saturation 88% on room air

Section 1

As the healthcare team initiates the initial assessment, it becomes evident that the patient's condition is rapidly deteriorating. The patient's skin is cool and clammy with pronounced pallor, indicative of significant hemodynamic instability. Her respiratory effort appears labored, with accessory muscle use and intercostal retractions, suggesting worsening respiratory distress. Auscultation reveals diminished breath sounds bilaterally, and crackles are noted, raising concerns of potential pulmonary edema or acute respiratory distress syndrome (ARDS) secondary to systemic inflammation and fluid shifts. Cardiac examination indicates tachycardia with a rapid, thready pulse, and a possible S3 gallop, which may signify early heart failure. Mental status assessment shows increasing disorientation and lethargy, aligning with potential cerebral ischemia.

Laboratory investigations return with alarming results. The complete blood count reveals severe thrombocytopenia with a platelet count of 25,000/mm³, while the hemoglobin has dropped to 7.5 g/dL, signifying substantial blood loss and anemia. Coagulation studies show prolonged prothrombin time (PT) at 22 seconds and activated partial thromboplastin time (aPTT) at 60 seconds, confirming a coagulopathy consistent with DIC. Fibrin degradation products and D-dimer levels are markedly elevated, highlighting extensive fibrinolysis. Renal function tests indicate worsening kidney function with a serum creatinine of 3.8 mg/dL, exacerbating her existing chronic kidney disease, while liver function tests reveal elevated transaminases, pointing towards hepatic involvement.

The healthcare team discusses the urgent need for targeted interventions, including volume resuscitation, transfusion of blood products, and potential organ support measures. However, the patient's rapidly evolving condition poses significant challenges in balancing the management of coagulopathy while preventing further thrombotic events. Continuous monitoring and reassessment are imperative as the risk of additional complications, such as acute kidney injury requiring dialysis or progression to multi-organ failure, looms large. The complexity of this case demands vigilant clinical reasoning and swift, decisive action to navigate the precarious balance between hemostatic control and end-organ perfusion.

Section 2

As the healthcare team implements initial interventions, the patient's condition exhibits alarming changes, indicating a critical shift in her clinical status. Despite aggressive fluid resuscitation and the initiation of blood product transfusions, her hemodynamic instability persists. Her blood pressure declines further to 80/50 mmHg, and her heart rate escalates to 140 beats per minute, suggesting refractory shock. The jugular venous pressure is elevated, and peripheral edema becomes more pronounced, raising concerns about worsening heart failure and possible cardiogenic shock.

Simultaneously, the patient's respiratory status deteriorates. Arterial blood gas analysis now reveals severe hypoxemia with a PaO2 of 55 mmHg and metabolic acidosis with a pH of 7.28, confirming the progression to acute respiratory distress syndrome (ARDS). The decision is made to intubate and mechanically ventilate the patient to ensure adequate oxygenation and ventilation. Despite these efforts, her oxygen saturation struggles to rise above 85%, highlighting the severity of her pulmonary compromise.

In the midst of these challenges, the patient's renal function takes a critical turn for the worse, with urine output dropping to less than 10 mL/hour, indicating acute kidney injury progressing towards potential renal failure. The nephrology team is consulted for urgent dialysis consideration. Concurrently, neurological status continues to decline, with the patient becoming unresponsive to verbal stimuli, necessitating a CT scan of the brain to rule out cerebral hemorrhage as a complication of her DIC. The healthcare team remains in a state of high alert, balancing multiple organ dysfunctions while trying to stabilize the patient's precarious condition.

Section 3

As the healthcare team continues to manage the patient's complex and rapidly evolving condition, a new set of diagnostic results returns, providing crucial insights into the underlying pathophysiology. The latest coagulation profile shows further derangement, with the prothrombin time (PT) extending to 30 seconds, and the activated partial thromboplastin time (aPTT) is now greater than 70 seconds. Fibrinogen levels have plummeted to 100 mg/dL, and D-dimer levels are alarmingly high, confirming the exacerbation of disseminated intravascular coagulation (DIC). These results underscore the hypercoagulable state while paradoxically increasing the risk for bleeding, prompting the hematology team to intensify their focus on balancing anticoagulation and transfusion strategies.

In conjunction with the coagulation abnormalities, the complete blood count reveals a precipitous drop in platelet count to 25,000/µL, exacerbating the patient's risk for spontaneous bleeding. To compound the challenge, a repeat echocardiogram identifies a severely reduced ejection fraction of 25%, confirming the progression to cardiogenic shock. This finding necessitates the initiation of inotropic support with dobutamine to improve cardiac output and tissue perfusion. However, the patient's overall hemodynamic status remains precarious, with frequent episodes of ventricular tachycardia further complicating the clinical picture.

As the team grapples with these developments, the patient's neurological status continues to deteriorate. The CT scan of the brain reveals multiple small, scattered infarcts, likely embolic in nature, contributing to her decreased responsiveness and unresponsiveness to verbal stimuli. This neurological decline poses an additional layer of complexity, requiring a multidisciplinary approach to prevent further cerebral insult while managing the underlying DIC. These findings catalyze a critical reassessment of therapeutic priorities, highlighting the urgent need for a coordinated, multi-system intervention strategy to stabilize the patient and prevent further organ dysfunction.

Section 4

The healthcare team's concerted efforts to manage the patient's multifaceted condition have led to a partial stabilization of her hemodynamic status. However, new complications have emerged, demanding immediate attention and advanced clinical judgment. Despite the initiation of dobutamine, the patient's cardiac rhythm disturbances have worsened, with sustained episodes of ventricular tachycardia now becoming more frequent and resistant to antiarrhythmic therapy. A 12-lead ECG confirms these arrhythmias, and telemetry strips show a concerning pattern of polymorphic ventricular tachycardia indicative of potential progression to torsades de pointes, necessitating the consideration of magnesium sulfate infusion and potential overdrive pacing.

Simultaneously, the patient's renal function exhibits signs of acute deterioration. Serum creatinine has sharply risen to 3.5 mg/dL from a baseline of 1.2 mg/dL, and urine output has decreased to less than 15 mL/hour, raising the specter of acute kidney injury secondary to both cardiogenic shock and ongoing DIC. This renal compromise is compounded by electrolyte imbalances, with hyperkalemia (potassium level at 5.8 mmol/L) and metabolic acidosis (arterial blood gas showing pH 7.25, HCO3- 18 mEq/L) further complicating her clinical status. Nephrology is consulted to evaluate the need for renal replacement therapy, while the critical care team adjusts diuretic and electrolyte management to address these abnormalities without exacerbating hypotension.

The patient's respiratory function also shows signs of compromise, with arterial blood gas analysis revealing hypoxemia (PaO2 60 mmHg on 60% FiO2) and hypercapnia (PaCO2 55 mmHg), indicative of evolving acute respiratory distress syndrome (ARDS). Lung auscultation reveals bilateral crackles, and chest X-ray findings suggest diffuse alveolar infiltrates. In light of these developments, the multidisciplinary team must consider the judicious escalation of ventilatory support, potentially transitioning to high-frequency oscillatory ventilation or extracorporeal membrane oxygenation (ECMO) as salvage therapies if conventional mechanical ventilation fails to stabilize her respiratory parameters. This critical juncture underscores the necessity for meticulous coordination across specialties to prioritize and sequence interventions that address the cascade of systemic failures while mitigating further complications.

Section 5

As the team diligently monitors the patient's evolving condition, a sudden change in her neurological status prompts immediate concern. The patient, previously alert and oriented, now exhibits a decreased level of consciousness, responding only to painful stimuli. Her Glasgow Coma Scale score has dropped to 8, necessitating a rapid assessment of potential cerebral complications. A stat CT scan of the head is ordered to rule out intracranial hemorrhage or ischemic events that could be precipitated by the ongoing DIC and hemodynamic instability. Meanwhile, the critical care team reviews the possibility of metabolic encephalopathy, given her severe metabolic acidosis, electrolyte imbalances, and compromised renal function.

Upon receiving the CT scan results, the team identifies multiple small cerebral infarcts consistent with a thromboembolic phenomenon possibly related to microvascular thrombosis from DIC. This finding compounds the complexity of her clinical picture, as anticoagulation therapy must be balanced against the risk of exacerbating her bleeding diathesis. Concurrently, her vital signs reveal a further decline in blood pressure, now measuring 85/50 mmHg, with a heart rate of 120 beats per minute, indicating a progression to profound shock. This necessitates an intensification of vasopressor support, with the addition of norepinephrine to maintain adequate cerebral and systemic perfusion.

In response to these critical developments, the multidisciplinary team convenes to reassess the treatment priorities, focusing on stabilizing her hemodynamic status while addressing the neurological compromise. Neurology is actively engaged to provide input on managing potential cerebral complications without further destabilizing her coagulation profile. The evolving scenario demands a strategic approach, weighing the risks and benefits of therapeutic interventions to prevent further systemic deterioration. As the patient's journey continues, the team remains vigilant, anticipating further challenges and adapting their clinical strategies to optimize outcomes in this precarious situation.